True Wealth Design’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2
Closed -$4 – 2823
2026
Q2
$4 Sell
2
-7
-78% -$22 ﹤0.01% 2654
2026
Q1
$29 Buy
+9
New +$35 ﹤0.01% 2615

Other funds holding TVRD

True Wealth Design's TVRD Position: Q3 2026 in Review

True Wealth Design sold out of Tvardi Therapeutics (TVRD) in Q3 2026, closing a stake of 2 shares — an estimated $4 sold.

True Wealth Design first reported a position in TVRD in Q1 2026 and held it in 2 quarters. The position peaked at $29 in Q1 2026. 62 funds tracked by Wall St. Rank hold TVRD as of Q3 2026.

  • True Wealth Design reported no remaining Tvardi Therapeutics position as of Q3 2026 after selling out during the quarter.
  • True Wealth Design sold 2 Tvardi Therapeutics shares in Q3 2026, an estimated $4.
  • True Wealth Design first reported a position in Tvardi Therapeutics in Q1 2026 and held it in 2 quarters.
  • True Wealth Design's Tvardi Therapeutics position peaked at $29 in Q1 2026.
  • 62 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.